Lee Dong Hun, Lee Byung Kook, Jeung Kyung Woon, Jung Yong Hun, Lee Sung Min, Cho Yong Soo, Yun Seong-Woo, Min Yong Il
Department of Emergency Medicine, Chonnam National University Hospital, 42 Jebong-ro, Donggu, Gwangju, Republic of Korea.
Department of Emergency Medicine, Chonnam National University Hospital, 42 Jebong-ro, Donggu, Gwangju, Republic of Korea.
Am J Emerg Med. 2017 Nov;35(11):1617-1623. doi: 10.1016/j.ajem.2017.04.077. Epub 2017 May 1.
We aimed to examine the serial changes in coagulofibrinolytic markers that occurred after the restoration of spontaneous circulation (ROSC) in cardiac arrest patients, who were treated with targeted temperature management (TTM). We also evaluated the association between the disseminated intravascular coagulation (DIC) score and clinical outcomes.
This was a single-centre, retrospective observational study that included cardiac arrest patients who were treated with TTM from May 2012 to December 2015. The prothrombin time (PT) and partial thromboplastin time (PTT), along with the levels of fibrinogen, fibrin degradation products (FDP), and D-dimer were obtained after ROSC and on day 1, 2, and 3. The DIC score was calculated after ROSC. The primary outcome was the neurologic outcome at discharge and the secondary outcome was the 6-month mortality.
This study included 317 patients. Of these, 222 (70.0%) and 194 (61.2%) patients had a poor neurologic outcome at discharge and 6-month mortality, respectively. The PT, PTT, and fibrinogen level significantly increased over time, while the FDP and D-dimer levels decreased during first three days after ROSC. Multivariate logistic analyses revealed that the DIC score remained a significant predictor for poor neurologic outcome (odds ratio [OR], 1.800; 95% confidence interval [CI], 1.323-2.451) and 6-month mortality (OR, 1.773; 95% CI, 1.307-2.405).
The activity of coagulation and fibrinolysis decreased over time. An increased DIC score was an independent prognostic factor for poor neurologic outcome and 6-month mortality.
我们旨在研究接受目标温度管理(TTM)的心脏骤停患者自主循环恢复(ROSC)后凝血纤溶标志物的系列变化。我们还评估了弥散性血管内凝血(DIC)评分与临床结局之间的关联。
这是一项单中心回顾性观察研究,纳入了2012年5月至2015年12月接受TTM治疗的心脏骤停患者。在ROSC后以及第1、2和3天获取凝血酶原时间(PT)、活化部分凝血活酶时间(PTT)以及纤维蛋白原、纤维蛋白降解产物(FDP)和D-二聚体水平。ROSC后计算DIC评分。主要结局是出院时的神经学结局,次要结局是6个月死亡率。
本研究纳入317例患者。其中,分别有222例(70.0%)和194例(61.2%)患者出院时神经学结局不良和6个月死亡率高。PT、PTT和纤维蛋白原水平随时间显著升高,而ROSC后的前三天FDP和D-二聚体水平降低。多因素逻辑分析显示,DIC评分仍然是神经学结局不良(比值比[OR],1.800;95%置信区间[CI],1.323 - 2.451)和6个月死亡率(OR,1.773;95% CI,1.307 - 2.405)的显著预测因素。
凝血和纤溶活性随时间降低。DIC评分升高是神经学结局不良和6个月死亡率的独立预后因素。